Remove Independent Pharmacies Remove Prescription Filling Remove Specialty Pharmacies
article thumbnail

The Lilly Digest

Ramblings of a pharmacist

The NCPA Digest reports that the GDR for independent pharmacies was only 86% for 2020.” ” Including compounds with brands will understate the GDR, with generics will overstate the GDR, and excluding compounds will deflate the volume of the pharmacy, increasing the calculated cost of dispensing.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

Key Medicare tools to safeguard against pharmacy fraud and inappropriate billing do not apply to Part D. NHC comments to the FTC on PBM business practices and the impact on independent pharmacies and consumers. Pharmacy benefit managers: transparency, accountability, and impact on patient care. Blendon, R., Casalino, L.,